Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis
J Am Acad Dermatol
.
2021 Aug;85(2):512-513.
doi: 10.1016/j.jaad.2018.09.063.
Epub 2019 Jan 8.
Authors
Radhika Shah
1
,
Steven T Chen
1
,
Daniela Kroshinsky
2
Affiliations
1
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
2
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: dkroshinsky@partners.org.
PMID:
30630021
DOI:
10.1016/j.jaad.2018.09.063
No abstract available
Publication types
Letter
MeSH terms
Adolescent
Adult
Aged
Cyclosporine / therapeutic use*
Female
Humans
Male
Middle Aged
Retrospective Studies
Stevens-Johnson Syndrome / drug therapy*
Young Adult
Substances
Cyclosporine